Engineered Stem Cells Can Home In On Tumors And Deliver Drug Payload In Mice

Researchers at The University of Texas M. D. Anderson Cancer Center have perfected a delivery system for anticancer treatment that zeroes in on a tumor and becomes part of its supporting tissue. This new “cellular vehicle” then pumps drugs directly into cancer cells to disable them, but leaves normal tissue alone. They say their study, published in the Journal of the National Cancer Institute, is a proof of principle, conducted in mice, that shows this kind of strategy could be promising when developed for human use.